hsCRP Clinical Trial
Official title:
High-sensitivity C-reactive Protein (hsCRP) in the Prognosis of Patients After Coronary Intervention (PCI) : a Multi-center Prospective Study
Coronary heart disease (CAD) is caused by myocardial ischemia, hypoxia or necrosis due to coronary artery stenosis, spasm or obstruction. Although standard drug therapy can greatly improve the prognosis of patients with CAD after percutaneous coronary interventions (PCI), these patients are still at high risk of major adverse cardiovascular and cerebrovascular events (MACCE). At present, the concept of residual inflammation risk (RIR) has aroused widespread concern. RIR is an important independent risk in patients with CAD. Previous studies indicated that hsCRP ≥ 2mg / L was the definition standard of RIR in CAD in European and American people. In China, the impact of dynamic changes of hsCRP on MACCE in PCI population remains unclear. Therefore, in this study, the investigators plan to recruit patients undergoing PCI, and observe the impact of RIR by serial hsCRP measurements on the prognosis of these patients followed up for 1 years at 14 hospitals in China.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05130892 -
Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI
|
Phase 4 | |
| Recruiting |
NCT05131750 -
RIR and the Impact on Clinical Outcomes in Patients Undergoing PCI
|
||
| Recruiting |
NCT01852240 -
Periodontal Disease as a Risk Indicator for Erectile Dysfunction - A Cross-sectional Study on 100 Patients
|
N/A | |
| Recruiting |
NCT06362759 -
A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP
|
Phase 2 | |
| Completed |
NCT00819273 -
Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population
|
N/A |